Position
Chief Medical Officer
Company
Solu Therapeutics
Description
Solu Therapeutics announced the appointment of Sergio Santillana, MD, MSc, MBA, as Chief Medical Officer (CMO). Dr. Santillana brings deep expertise in drug development and a proven track record of bringing therapies to market, making him a vital resource in the mission to develop transformative treatments for patients living with cancer, immunological diseases, and other serious illnesses
Quick answer
Solu Therapeutics Appoints Sergio Santillana as Chief Medical Officer (September 10, 2024). Solu Therapeutics is based in Boston, Massachusetts, United States.
- Who is the new Chief Medical Officer at Solu Therapeutics?
- Solu Therapeutics named Sergio Santillana Chief Medical Officer, announced September 10, 2024.
- What did Solu Therapeutics announce on September 10, 2024?
- Solu Therapeutics announced the appointment of Sergio Santillana, MD, MSc, MBA, as Chief Medical Officer (CMO).
- What does Solu Therapeutics do?
- Solu Therapeutics, a precision-medicine company, is developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity.
- Where is Solu Therapeutics based?
- Solu Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Tyra Biosciences (September 10, 2024), Cue Biopharma (September 9, 2024), AAVantgarde Bio (September 9, 2024) and Alchemab Therapeutics (September 12, 2024) also announced leadership changes within 45 days of Solu Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Tyra Biosciences Appoints Doug Warner, M.D. as Chief Medical Officer (September 10, 2024)
- Cue Biopharma Appoints Lucinda Warren as Chief Business Officer (September 9, 2024)
- AAVantgarde Names Jayashree Sahni as Chief Medical Officer (September 9, 2024)
- Jane Osbourn Succeeds Young Kwon as CEO of Alchemab Therapeutics (September 12, 2024)
- Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer (CFO) (September 13, 2024)
- NYU Langone Appoints Roxana Fu, MD as Chief of Oculoplastics (September 6, 2024)
Who to call at Solu Therapeutics, and when
A new leader at Solu Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Solu Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Solu Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Solu Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Solu Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Solu Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.